AeroNabs Antiviral Nasal Spray Developed By UCSF Researchers To Help Prevent Coronavirus Infection

a woman using nasal spray

A team of researchers at the University of California, San Francisco have developed a nasal spray that can ward off the coronavirus, The Sacramento Bee reported. The treatment wouldn’t require a prescription and could be sold over the counter.

AeroNabs, as the product is being called, is not being touted as a cure; indeed, no cure for COVID-19, the respiratory illness caused by the coronavirus, exists. Rather, the nasal spray is purportedly a preventative.

Specifically, says the lead researcher, UCSF graduate student Michael Schoof, the team developed a synthetic molecule that operates as a potent antiviral that blocks SARS-CoV-2 — the pathogen colloquially referred to as the “novel coronavirus” — from taking hold within the body.

Schoof and his partner, AeroNabs co-inventor Peter Walter, professor of biochemistry and biophysics at UCSF, were inspired by nanobodies, proteins similar to antibodies (found in humans) that occur naturally in llamas, camels and related animals.

Click here to continue and read more...

Share on Google Plus
    Blogger Comment
    Facebook Comment

0 comments :

Post a Comment